BSE filing, NSE: SMT. Summary written from the filing by ALFA Finder's alert engine.
Sahajanand Medical Technologies Ltd: key numbers
- Share price
- ₹483.00
- Market cap
- ₹4,910 Cr
- Revenue (annual)
- ₹1,210 Cr
- Net profit (annual)
- ₹65.28 Cr
- Promoter holding
- 36.20%
- FII holding
- 35.09%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sahajanand Medical Technologies Ltd
All →Sahajanand Medical Technologies Legal & Regulatory
Sahajanand Medical Technologies received a GST DRC-01D recovery notice from Jharkhand tax authorities. The demand totals Rs. 34.29 lakh, which the company is contesting before appellate authorities.
- Value
- ₹0.34 Cr
Sahajanand Medical Technologies Credit Rating
CRISIL has upgraded Sahajanand Medical Technologies' long-term bank facility rating to CRISIL A-/Stable from BBB+/Stable. The upgrade reflects improved business risk, growing scale, and sustained profitability across its global stent manufacturing operations.
- Value
- ₹300.0 Cr
Sahajanand Medical Technologies Capital Structure Change
Invesco Mutual Fund schemes bought 44,20,453 Sahajanand Medical Technologies shares in the open market. Their stake rose to 5.0549%, with no transaction price disclosed.
Sahajanand Medical Technologies Board Meeting Date
Sahajanand Medical Technologies scheduled a board meeting for 5 November 2026 to consider Q2 and half-year financial results. No financial figures are disclosed yet.
Sahajanand Medical Technologies Legal & Regulatory
Sahajanand Medical Technologies received a DGGI summons under GST Act Section 70 for books verification. The company says there is no material financial impact at this stage.
Other other announcement announcements
All →Larsen & Toubro Other Announcement
Larsen & Toubro's RTA, KFin Technologies, is relocating its corporate office effective December 1, 2026. The filing is an administrative address-change intimation with no financial impact.
Vikas WSP Other Announcement
Vikas WSP filed its quarterly shareholding pattern for the quarter ended September 30, 2026. It is a routine Regulation 31 disclosure with no transaction or corporate event.
Shalby Other Announcement
Shalby Limited disclosed under Regulation 30(5) that the board authorised KMP personnel for materiality determination. Mr. Tushar Shah's designation was revised after his appointment as Executive Director.
Aimtron Electronics Other Announcement
Aimtron Electronics confirmed no deviation in preferential warrant fund use for the half year ended 30 September 2026. This routine Regulation 32 statement reports no new transaction.
Asset Reconstruction Company (India) Other Announcement
Asset Reconstruction Company (India) filed its quarterly shareholding pattern for the period ended 30 September 2026. Avenue India Resurgence, a promoter, holds 60.88 percent of the company.
Jivial Industries Other Announcement
Jivial Industries Ltd filed its quarterly shareholding pattern for the period ended 30 September 2026. Promoters hold 61.17% of equity, with the public holding the remainder.